Breaking
McLEAN, VA - Verato answers healthcare's hardest question: who is who? Referential Matching checks records against 30 years of U.S. demographic data Verato UMPI ranked #1 EMPI by Black Book Research Revenue roughly doubled to $35.5M in 2024 hMDM named a Fierce Healthcare Innovation Awards 2025 winner First customers: the DoD and the Veterans Health Administration McLEAN, VA - Verato answers healthcare's hardest question: who is who? Referential Matching checks records against 30 years of U.S. demographic data Verato UMPI ranked #1 EMPI by Black Book Research Revenue roughly doubled to $35.5M in 2024 hMDM named a Fierce Healthcare Innovation Awards 2025 winner First customers: the DoD and the Veterans Health Administration
Company Profile  /  Health Technology McLean, Virginia · Est. 2012

Verato: knowing who is who.

The healthcare identity company that turned an old, unglamorous problem - duplicate patient records - into cloud infrastructure trusted by hospitals, payers, and government.

Verato company logo

Verato, Inc. - the wordmark of a company whose product is quietly deciding, millions of times a day, whether two records belong to the same person.

Share LinkedIn Twitter / X Facebook Instagram
The Story

A company built on one question

In healthcare, almost everything downstream depends on a fact that is surprisingly hard to establish: that two records belong to the same person. A misspelled name, a former address, a new insurance card, a maiden name - any of these can quietly split one patient into two, or fuse two patients into one. Verato exists to prevent that, and it has spent more than a decade making the job look routine.

Founded in 2012 - originally under the name Araxid - and rebranded to Verato in 2015, the company sells cloud software that links, cleans, verifies, and enriches identity records across large healthcare organizations. Its headquarters sit in McLean, Virginia, and its customer list runs from hospitals and health systems to insurers, health information exchanges, life sciences firms, and public agencies.

The founder, Mark LaRow, came to the problem from an unusual direction. He had been chief technology officer at the credit bureau Equifax, where he saw how error-prone identity databases can be. Later, navigating his own medical care across multiple providers, he watched a health system fail to recognize him in its own records. A former Navy submarine officer, LaRow started the company with an engineer's instinct: build the missing reference layer that everyone else assumed was someone else's job.

Today Verato is led by chief executive Clay Ritchey, a healthcare-technology veteran who previously ran the CRM and analytics company Evariant and held senior roles at Imprivata and Hill-Rom. Under his tenure the company has widened its pitch from patient matching to a broader idea it calls master data management for healthcare - but the core has not moved. It is still, at bottom, about knowing who is who.

By The Numbers

Verato at a glance

2012
Founded
~$35.5M
2024 Revenue
~176
Employees
#1
EMPI, Black Book
30 yrs
Reference Data Depth
~$35M
Venture Raised
20+
Public Health Deployments
2015
Verato Rebrand
"Solving the problem that drives everything else - knowing who is who."
Verato company mission
The Technology

Referential Matching, explained

Most patient-matching systems compare two records against each other and estimate the odds that they describe the same person. That is probabilistic matching, and it struggles the moment the data changes - a new surname, an old ZIP code, a transposed birthday.

Verato's approach adds a second reference point. Instead of only weighing record A against record B, it checks both against a proprietary database of U.S. demographic information carrying up to 30 years of history. That database acts like an answer key: if a person's maiden name and current name both appear in the reference set, Verato can connect records that a conventional system would leave stranded.

The company packaged this first as Verato Universal MPI, a cloud-native enterprise master person index, and later folded it into a wider platform. In 2024 it was granted a patent covering the referential-matching method, and it has published independently verified accuracy results - a rare thing in a field where every vendor claims to be the most accurate.

The practical payoff is unglamorous but real. Fewer duplicate records means fewer denied claims, less repeated testing, fewer moments where a clinician is looking at half a chart. For an emergency department or a health information exchange stitching a region together, a single point of matching accuracy compounds across every workflow it touches.

Products & Services

What Verato sells

2025

Verato MDM Cloud

The current flagship. Master data management that combines identity resolution and enrichment with insights, identity verification, and data governance in one cloud platform.

2024

Verato hMDM

Master data management purpose-built for healthcare, designed to replace and extend legacy EMPI. Named a Fierce Healthcare Innovation Awards 2025 winner.

2017

Verato Universal MPI

Cloud-native enterprise master person index that resolves patient and member identities across systems. Ranked #1 EMPI by Black Book Research.

2015

Referential Matching

The core engine: probabilistic algorithms paired with a reference database of U.S. demographics used as an answer key. Patented in 2024.

Ongoing

Identity Verification

Real-time checks that confirm a person is who they claim to be, layered on top of resolution for onboarding and engagement.

Ongoing

Data Enrichment & Governance

Cleaning, appending, and stewarding identity data so downstream analytics and CRM systems inherit a trustworthy 360-degree view.

The Difference

Why organizations pick it

Verato positions itself as the identity layer that sits beneath analytics, CRM, and interoperability - not a feature inside any one of them. These illustrative bars sketch how the company frames its edge over conventional matching. Figures reflect Verato's positioning rather than a formal benchmark.

Referential Matching depth (reference-database backed)Verato
Cloud-native EMPI / MDM footprintVerato
Healthcare-purpose-built (hMDM)Verato
Typical probabilistic-only matchingLegacy baseline
The Market

Who uses it, and how it makes money

The customers

Hospitals and health systems, healthcare payers, health information exchanges, public health agencies, life sciences companies, and government organizations. Named customers include Healthix, Contexture, Northwell Health, Atlantic Health, Intermountain, and Banner Health. Verato says its EMPI has been deployed by more than 20 public health organizations and HIEs, and that a large share of the U.S. population flows through its identity systems.

The business model

Verato is B2B SaaS. It licenses its cloud identity and master-data platform on recurring subscriptions, generally scaled to record volume and the identity services consumed. That model rewards accuracy and retention: institutions that stake patient safety and billing on the match tend to keep renewing, which is one reason revenue roughly doubled to about $35.5M in 2024 with fewer than 200 employees.

Where it fits

Verato competes with legacy and modern EMPI and MDM vendors - IBM's Initiate lineage, Oracle, Informatica, NextGate, Lyniate/Rhapsody, and Datavant - as well as the matching built into EHRs like Epic and Oracle Health. Its wedge is treating identity as standalone infrastructure rather than a bundled feature.

The partnerships

The platform plugs into the broader health-data stack through partnerships with Salesforce (including a healthcare app), Snowflake, Google Health Data Engine, and identity-verification firm CLEAR - positioning Verato as the identity spine other systems can lean on.

"Its first customers were the ones that could least afford to lose track of a person - the DoD and the VA."
On Verato's origins
The Record

A timeline

2012

Founded as Araxid

Mark LaRow, a former Equifax CTO and Navy submarine officer, starts the company to fix error-prone identity data.

2015

Rebrands as Verato, introduces Referential Matching

The company adopts the Verato name and commercializes its reference-database matching approach.

2017

Universal MPI launches; $12.5M Series B

Cloud-native EMPI debuts, backed by Bessemer Venture Partners and Columbia Capital.

2019

$10M Series C

Blue Heron Capital and the California Health Care Foundation join to fund expansion.

2022

Universal Identity platform

Verato broadens toward a unified identity offering across industries.

2023

HITRUST certification & CLEAR partnership

Security certification and a tie-up with CLEAR on identity verification.

2024

Referential-matching patent & hMDM

A patent is granted and healthcare-purpose-built MDM ships; revenue roughly doubles to ~$35.5M.

2025

Verato MDM Cloud & Fierce award

The company launches MDM Cloud and wins a Fierce Healthcare Innovation Award for hMDM.

Questions

Frequently asked

What does Verato do?

Verato is a healthcare identity data company. Its cloud platform links, cleans, verifies, and enriches patient and member records so organizations can maintain a single, accurate view of each person across systems.

What is Referential Matching?

It is Verato's core technology. Rather than only comparing two records against each other, it checks them against a proprietary reference database of U.S. demographic data with up to 30 years of history, using it as an answer key to resolve errors and inconsistencies.

Who uses Verato?

Hospitals and health systems, payers, health information exchanges, public health agencies, life sciences companies, and government organizations - including customers like Healthix, Contexture, Northwell Health, and Intermountain.

Who founded Verato and when?

Verato was founded in 2012 (originally as Araxid) by Mark LaRow, a former CTO of Equifax. It rebranded to Verato in 2015. Clay Ritchey is the current CEO.

How much funding has Verato raised?

Verato has raised roughly $35M in venture funding across rounds including a $12.5M Series B (2017) and a $10M Series C (2019), from investors such as Bessemer Venture Partners, Columbia Capital, Blue Heron Capital, and the California Health Care Foundation.